The Harvard Drug Group LLC

The Harvard Drug Group LLC: 4 recalls listed since March 2026 across FDA.

By year

Methylergonovine Maleate Tablets are subpotent.

Moderate riskFDAJun 22, 2026Wrong drug strength

Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram failed capsule specifications for loss on drying of capsule shells.

Moderate riskFDAApr 17, 2026Quality testing problem

Memantine Hydrochloride Extended-Release Capsules failed dissolution specifications.

Moderate riskFDAApr 10, 2026Drug dissolving problem

Midodrine Hydrochloride Tablets have defective containers and inadequately sealed blister packaging.

Moderate riskFDAMar 3, 2026Packaging defect